Navigation Links
Group B Strep Down Among Newborns, Up Among Adults

Study calls vaccination trials for mothers, new treatments for elderly a priority

FRIDAY, May 9 (HealthDay News) -- Instances of Group B streptococcus, a major cause of serious infections, have dropped by about 25 percent among week-old infants, but rose by almost 50 percent among most adults during a recent six-year period, according to a new study.

Group B strep is the leading cause of sepsis and meningitis in the first week of life. Prevention strategies put in place during the 1970s have helped quell the condition, called early-onset disease. However, an estimated 21,500 cases of invasive disease and 1,700 deaths were traced to the disease during 2005, according to the study, published in the May 7 issue of Journal of American Medical Association.

Group B streptococcus can also cause invasive disease in older infants, pregnant women, children and young adults with underlying medical conditions and older adults. An increase in disease incidence among non-pregnant adults has been previously documented in past decades.

The new study, which examines data on laboratory-confirmed invasive group B streptococcal disease in 10 states from 1999 to 2005, found 14,573 cases of the disease overall. Of those, 1,232 cases where early-onset disease.

Incidence decreased among week-old infants by 27 percent after the early-onset disease prevention guidelines were revised in 2002. Incidence remained flat among babies age 7 days to 89 days and pregnant women.

Among those age 15 to 64 years, Group B strep increased 48 percent. Occurrence of the disease increase by 20 percent among those 65 years or older experienced a 20 percent increase.

The proportion of patients who died was highest in the oldest age groups.

All strains of Group B strep tested were vulnerable to the antibiotics penicillin, ampicillin, and vancomycin, but 32 percent and 15 percent were resistant to erythromycin and clindamycin, respectively.

The study's authors concluded that group B streptococcus vaccination trials for mothers should become a priority, followed by vaccine development to help the elderly and younger adults with chronic underlying conditions.

More information

The Group B Strep International has more about Group B streptococcus .

-- Kevin McKeever

SOURCE: JAMA Archives journals, news release, May 6, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Long Term Care Group, Inc. Announces Hiring of New CIO
2. Cowen Group, Inc. Announces 2008 First Quarter Results
3. The Ensign Group, Inc. Reports First Quarter 2008 Earnings
4. Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain-Related Illness
5. Leading Advocacy Groups Set National Diabetes Goal
6. AMERIGROUP Corporation to Present at the Citigroup 2008 Global Healthcare Conference on May 21
7. Cadient Group Continues Winning Streak; Receives Multiple Honors at 2008 Pharmaceutical Advertising and Marketing Excellence Awards
8. Customer Communications Group Selected by The Childrens Hospital for Direct Marketing Expertise
9. First-Ever Group of Hospital Security Officers to Strike over Unfair Labor Practices, Walk out of Facilities Across California on May 6
10. AMERIGROUP Corporation to Webcast Annual Meeting of Stockholders on May 8, 2008
11. Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc.
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... 2015 , ... Many people know of the common symptoms of low thyroid ... skin. But many people who find their cholesterol levels and weight are creeping up ... especially if they don’t have any of the other symptoms. , Thyroid hormone plays ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for Tuberous Sclerosis Complex (TSC), as well as raising public awareness of the ... they need it—presented a third donation of $35,000 to bolster progress at the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in ... involving adult stem cell therapies to patients with chronic degenerative medical conditions. Now, ... a Registered Trademark (RTM). , Organizations are required to hold a registered trademark ...
(Date:11/25/2015)... ... November 25, 2015 , ... Students and parents have something to ... of the Create Real Impact awards. California Casualty is proud to support ... tide of distracted and reckless driving, the number one killer of young drivers. ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
(Date:11/25/2015)... 25, 2015  Mindray Medical International ... MR ), a leading developer, manufacturer ... today announced that it will hold ... shareholders at the Company,s Hong Kong office (FLAT/RM ... Edward West Road, Mongkok KL, Hong Kong) ...
(Date:11/25/2015)... November 25, 2015 Developmental, commercial, ... boosting the profitability of pharmaceutical products, says GBI ... and regulatory/legal strategies all play a key role ... GBI Research . --> Developmental, ... key role in boosting the profitability of pharmaceutical products, ...
Breaking Medicine Technology: